Jianying Shi

Jianying Shi has a diverse work experience spanning various roles and positions. They are currently working as the Senior Director, R&D IT Business Partner at Editas Medicine since June 2022. Prior to this, Shi worked as the Director, R&D IT Business Partner at Akebia Therapeutics from May 2018 to April 2022. They also served as a Consultant - Head of Clinical Research Informatics Service at Dana-Farber Cancer Institute from May 2017 to May 2018. Notably, Shi held multiple positions at Ipsen, including Director, Global R&D Informatics from January 2013 to April 2017, and Project Director from April 2009 to December 2012. Additionally, they worked at various organizations such as BG-Medicine, Novartis, Broad Institute, Cereon Genomics/Monsanto, and Nankai University, where they gained expertise in strategic alliance management, bioinformatics, and teaching.

Jianying Shi holds a Ph.D in Molecular Biology from Oregon Health & Science University. Additionally, they have obtained an MS degree in Computer Science from Oregon Graduate Institute. Prior to that, Jianying Shi earned an MS degree in Biochemistry and a BS degree in Chemistry from Nankai University.